#germany-pharma

US launches investigation into Germany's drug pricing policies, raising tariff threat

The United States has initiated a formal investigation into Germany's pharmaceutical pricing regulations, potentially opening the door to punitive tariffs. The move signals Washington's growing frustration with European healthcare cost-control measures.